Simultaneous Determination of Multiple Anti‐Seizure Medications in Human Plasma Using High‐Performance Liquid Chromatography‐Tandem Mass Spectrometry with Positive/Negative Ion‐Switching Ionization Mode for Therapeutic Drug Monitoring
Journal of Separation Science · 2025
DOI: 10.1002/jssc.70151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Separation Science, 2025. Verfasst von Yu-Fei Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Anticonvulsants, Drug Monitoring. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Nature Science Foundation of China, Chinese Pharmaceutical Association Hospital Pharmacy Department, National Key R&D Program of China.
Abstract (Originalsprache)
Monotherapy or combination therapy with anti‐seizure medications (ASMs) remains the cornerstone of epilepsy treatment. Therapeutic drug monitoring is important for individualized ASM treatment and for optimizing outcomes in patients with epilepsy. Therefore, the simultaneous and accurate quantification of ASMs is necessary and helpful for clinical use. In this study, a new method was developed to simultaneously quantify carbamazepine, lacosamide, lamotrigine, levetiracetam, oxcarbazepine, perampanel, sodium valproate, topiramate, and an active metabolite of oxcarbazepine, 10, 11‐dihydro‐10‐hydroxycarbamazepine, in human plasma by high‐performance liquid chromatography‐tandem mass spectrometry using the positive/negative ion‐switching ionization mode. The method was assessed for accuracy, precision, linearity, recovery, and matrix effects according to the criteria of the U.S. Food and Drug Administration Bioanalytical Method Validation Guidelines for Industry for Bioanalytical Methods. The lower limit of quantification was determined to be 0.001–25 µg/mL for each analyte. The intra‐ and inter‐day precision values had
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Förderung
- National Nature Science Foundation of China
- Chinese Pharmaceutical Association Hospital Pharmacy Department
- National Key R&D Program of China
- National Key Research and Development Program of China
Zitieren
APA
Zhang, Y. F., Yu, Z., Zhao, Z., Xu, L. Q., Wu, X. Y., & Ma, C. L. (2025). Simultaneous Determination of Multiple Anti‐Seizure Medications in Human Plasma Using High‐Performance Liquid Chromatography‐Tandem Mass Spectrometry with Positive/Negative Ion‐Switching Ionization Mode for Therapeutic Drug Monitoring. Journal of Separation Science. https://doi.org/10.1002/jssc.70151
Vancouver
Zhang YF, Yu Z, Zhao Z, Xu LQ, Wu XY, Ma CL. Simultaneous Determination of Multiple Anti‐Seizure Medications in Human Plasma Using High‐Performance Liquid Chromatography‐Tandem Mass Spectrometry with Positive/Negative Ion‐Switching Ionization Mode for Therapeutic Drug Monitoring. Journal of Separation Science. 2025. doi:10.1002/jssc.70151
BibTeX
@article{Zhang2025,
author = {Zhang, Yu-Fei and Yu, Zheng and Zhao, Zhao and Xu, Le-Qing and Wu, Xun-Yi and Ma, Chun-Lai},
title = {Simultaneous Determination of Multiple Anti‐Seizure Medications in Human Plasma Using High‐Performance Liquid Chromatography‐Tandem Mass Spectrometry with Positive/Negative Ion‐Switching Ionization Mode for Therapeutic Drug Monitoring},
journal = {Journal of Separation Science},
year = {2025},
doi = {10.1002/jssc.70151}
}
EUVIMED